Back

15-month results of the MASTER DAPT trial.

29 August 2022 (08:48 - 08:58)
Organised by:
Congress Presentation Part of: HOT LINE SESSION 8 Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Marco Valgimigli

Cardiocentro Ticino Institute, Lugano (Switzerland)

14 More presentations in this session

Presentation thumbnail
ISCHEMIA-CKD EXTEND - Clinical Outcomes at 5 years of Follow-up.
Professor S. Bangalore (New York, US)
Slides Video
Presentation thumbnail
Discussant review - ISCHEMIA-CKD EXTEND.
Professor D. Bhatt (New York City, US)
Slides Video
Presentation thumbnail
Panel discussion - ISCHEMIA-CKD EXTEND.
Video
Presentation thumbnail
Discussant review - MASTER DAPT.
Professor S. Schuepke (Munich, DE)
Slides Video
Presentation thumbnail
Panel discussion - MASTER DAPT.
Video

Access the full session

Session thumbnail
HOT LINE SESSION 8
Video

The Event

Event poster

ESC Congress 2022

29 August 2022 08:48 CET
You may be interested in
thumbnail
Congress Session
Personalised dual antiplatelet therapy (DAPT) after acute coronary syndromes: difficult decisions
thumbnail
Congress Presentation
DAPT, monotherapy, or more? Rethinking antithrombotic strategies after percutaneous coronary intervention
thumbnail
Congress Session
Meet the Experts: de-escalating DAPT in acute coronary syndrome patients to reduce bleeding risk – what safe options do I have?

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources